• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

45.10 -0.96 (-2.08%)
Streaming Delayed Price Updated: 11:07 AM EDT, Jun 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico
February 10, 2026
Via ACCESS Newswire
News headline image
Should You Buy Moderna Before Feb. 13? ↗
February 09, 2026
The biotech has momentum as its quarterly report approaches. 
Via The Motley Fool
News headline image
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
As of February 6, 2026, Roivant Sciences (Nasdaq: ROIV) has firmly established itself as the preeminent "capital allocator" of the biotechnology sector. The company made headlines today with a... 
Via Finterra
Topics ETFs Economy Initial Public Offering
News headline image
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
February 05, 2026
Issued on behalf of Oncolytics Biotech Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
Tom Gardner's 2026 Outlook: Volatility, Government Scrutiny, and Two AI-Adjacent Stocks ↗
February 04, 2026
Tom Gardner outlines two selective AI opportunities and a disciplined portfolio framework for the next three to five years. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.
February 04, 2026
From Defiance ETFs
Via GlobeNewswire
Gapping S&P500 stocks in Monday's session ↗
February 02, 2026
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
January 30, 2026
Via Chartmill
Which S&P500 stocks have an unusual volume on Thursday? ↗
January 22, 2026
Via Chartmill
News headline image
Dr. David Berman to Join Moderna as Chief Development Officer
January 30, 2026
Via ACCESS Newswire
News headline image
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
January 29, 2026
Via ACCESS Newswire
News headline image
3 ETFs Catapulting Beyond the S&P to Start the Year ↗
January 29, 2026
Via MarketBeat
Topics ETFs Stocks
News headline image
This Stock Is Already Up 58% This Year. Is It a Buy? ↗
January 28, 2026
This forgotten pandemic stock hasn't said its last word. 
Via The Motley Fool
Monday's session: top gainers and losers in the S&P500 index ↗
January 26, 2026
Via Chartmill
Discover which S&P500 stocks are making waves on Monday. ↗
January 26, 2026
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
January 26, 2026
Via Chartmill
News headline image
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
As of January 26, 2026, Merck & Co. (NYSE: MRK) stands at the most critical juncture in its 135-year history. Known globally for its dominant oncology franchise and robust vaccine portfolio, the... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
1 Volatile Stock to Own for Decades and 2 We Ignore
January 25, 2026
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
MarketBeat Week in Review – 01/19 - 01/23 ↗
January 24, 2026
Via MarketBeat
Exploring the top movers within the S&P500 index during today's session. ↗
January 23, 2026
Via Chartmill
Which S&P500 stocks are moving on Friday? ↗
January 23, 2026
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
January 23, 2026
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Friday? ↗
January 23, 2026
Via Chartmill
These S&P500 stocks are moving in today's session ↗
January 22, 2026
Via Chartmill
News headline image
Moderna and Merck Solidify Oncology Leadership as Five-Year Melanoma Data Fuels Market Rally
January 22, 2026
In a landmark moment for the future of personalized medicine, Moderna, Inc. (NASDAQ: MRNA) and Merck & Co., Inc. (NYSE: MRK) announced groundbreaking five-year follow-up data on January 20, 2026, for... 
Via MarketMinute
Topics Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Thursday's session. ↗
January 22, 2026
Via Chartmill
Top S&P500 movers in Thursday's session ↗
January 22, 2026
Via Chartmill
News headline image
Moderna’s 2026 Pivot: From Pandemic Pioneer to Oncology Powerhouse
January 22, 2026
As of January 22, 2026, Moderna, Inc. (NASDAQ: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the poster child for the global pandemic response, the Cambridge-based... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Moderna Stock Explodes To New 52-Week High: What&#39;s Driving The Action? ↗
January 22, 2026
Moderna Inc (NASDAQ: MRNA) stock is trading higher Thursday morning, hitting a new 52-week high after new cancer trial data. 
Via Benzinga
These S&P500 stocks are moving in today's pre-market session ↗
January 22, 2026
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap